Literature DB >> 19756878

Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors.

Daniel Vallböhmer1, Jan Brabender, Ralf Metzger, Arnulf H Hölscher.   

Abstract

INTRODUCTION: Esophageal adenocarcinoma is the most rapidly increasing cancer in Western countries. Like esophageal squamous-cell carcinoma, these tumors are often detected at an advanced stage, requiring a multimodal concept. Despite improvements in detection, surgical resection, and (neo-) adjuvant therapy, the overall survival of esophageal cancer remains lower than other solid tumors. In fact, just 30-40% of the patients with advanced esophageal cancer benefit from a neoadjuvant therapy. Therefore, predictive/prognostic markers are needed to allow tailored multimodality therapy with increased efficacy. DISCUSSION: In recent years, there has been an exponential growth in our understanding of the cellular and molecular events associated with cell cycle regulation, programmed cell death, angiogenesis, and tumor growth. In this review, the classification of Hanahan and Weinberg is used concerning the six essential changes in carcinogenesis, i.e., the six hallmarks of cancer: (1) self-sufficiency in growth signals; (2) insensitivity to antigrowth signals; (3) avoidance of apoptosis; (4) limitless replicative potential; (5) sustained angiogenesis; and (6) tissue invasion and metastasis.
CONCLUSIONS: According to these six steps, this review provides an update of the most recent data about predictive/prognostic molecular markers in patients with esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756878     DOI: 10.1007/s11605-009-1021-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  50 in total

1.  High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.

Authors:  Huan Xi; Stephan E Baldus; Ute Warnecke-Eberz; Jan Brabender; Susanne Neiss; Ralf Metzger; Frederike C Ling; Hans P Dienes; Elfriede Bollschweiler; Stefan Moenig; Rolf P Mueller; Arnulf H Hoelscher; Paul M Schneider
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

2.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

3.  Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

Authors:  S Inada; T Koto; K Futami; S Arima; A Iwashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer.

Authors:  M Ikeguchi; M Maeta; N Kaibara
Journal:  Int J Mol Med       Date:  2001-04       Impact factor: 4.101

5.  Analysis of reduced death and complication rates after esophageal resection.

Authors:  B P Whooley; S Law; S C Murthy; A Alexandrou; J Wong
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 6.  Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus.

Authors:  Johannes Zacherl; Andreas Sendler; Hubert J Stein; Katja Ott; Marcus Feith; Raimund Jakesz; J Rüdiger Siewert; Ulrich Fink
Journal:  World J Surg       Date:  2003-08-28       Impact factor: 3.352

7.  Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma.

Authors:  Kuang-Tai Kuo; Kuan-Chih Chow; Yu-Chung Wu; Chen-Sung Lin; Hao-Wei Wang; Wing-Yin Li; Liang-Shun Wang
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

8.  Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.

Authors:  Makoto Sohda; Hitoshi Ishikawa; Norihiro Masuda; Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Minoru Fukuchi; Ryokuhei Manda; Yasuyuki Fukai; Hideyuki Sakurai; Hiroyuki Kuwano
Journal:  Int J Cancer       Date:  2004-07-20       Impact factor: 7.396

9.  Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.

Authors:  H Takatori; S Natsugoe; H Okumura; M Matsumoto; Y Uchikado; T Setoyama; K Sasaki; K Tamotsu; T Owaki; S Ishigami; T Aikou
Journal:  Eur J Surg Oncol       Date:  2007-06-05       Impact factor: 4.424

10.  Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; J A McKay; W T Melvin; J E Fothergill
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

View more
  15 in total

1.  S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.

Authors:  Dong Chen; Xue-Feng Zheng; Ze-You Yang; Dong-Xiao Liu; Guo-You Zhang; Xue-Long Jiao; Hui Zhao
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.

Authors:  Kai Liu; Yue Luo; Hui Tian; Kai-Zhong Yu; Jin-Xian He; Wei-Yu Shen
Journal:  Tumour Biol       Date:  2014-02

3.  Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

Authors:  Feiyan Deng; Keming Zhou; Wenli Cui; Dong Liu; Yuqing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.

Authors:  Yasushi Toh; Akinori Egashira; Manabu Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

Review 5.  Surveillance or resection after chemoradiation in esophageal cancer.

Authors:  Il-Hwan Park; Jae Y Kim
Journal:  Ann Transl Med       Date:  2018-02

6.  Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Ji-Yuan Li; Xin Ma; Can-Bin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 7.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

8.  Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Xiushan Zheng; Yunping Zhao; Xin Wang; Yunming Li; Ruwen Wang; Yaoguang Jiang; Taiqian Gong; Mengbin Li; Li Sun; Liu Hong; Xiaohua Li; Jie Liang; Guanhong Luo; Bin Jin; Jianjun Yang; Hongwei Zhang; Daiming Fan
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

9.  Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma.

Authors:  Peng Ren; Zhen-Tao Yu; Li Xiu; Mei Wang; Hua-Min Liu
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Downregulation of RIKP by miR-200a promotes the invasive ability of esophageal cancer cells by upregulating the expression of LIN28 and MMP-14.

Authors:  Qiuyun Yu; Jinhua Dai; Zhankun Zhu; Haibo Shen
Journal:  Int J Clin Exp Pathol       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.